• Bloodstream infections - Standard and progress in pathogen diagnostics.
  Lamy B, Sundqvist M, Idelevich EA et al. Clin Microbiol Infect 2020 doi: 10.1016/j.cmi.2019.11.017.

• Extended infusion of β-lactams for bloodstream infection in patients with
  liver cirrhosis: an observational multicenter study.
  Bartoletti M, Giannella M, Lewis RE. Clin Infect Dis 2019. doi: 10.1093/cid/ciz032.
• Microbiological diagnostics of bloodstream infections in Europe – An ESGBIES survey
  EA. Idelevich et al. Clinical Microbiology and Infection. 2019 pii: S1198-743X30143-0. doi:10.1016/j.cmi.2019.03.024
• External validation of the INCREMENT-CPE mortality score in a carbapenem-resistant Klebsiella pneumoniae bacteraemia cohort: the prognostic significance of colistin resistance.
  Machuca I, Gutiérrez-Gutiérrez B, Rivera-Espinar F, et al. Int J Antimicrob Agents 2019;54(4):442-448. doi: 10.1016/j.ijantimicag.2019.07.017.
• Bloodstream infections - Standard and progress in pathogen diagnostics.
  Lamy B, Sundqvist M, Idelevich EA et al. Clin Microbiol Infect 2019. pii: S1198-743X(19)30616-0. doi: 10.1016/j.cmi.2019.11.017.
• Bacterial bloodstream infection
  Allerberger F, Kern WV. Clin Microbiol Infect 2019. pii: S1198-743X30531-2. doi: 10.1016/j.cmi.2019.10.004.
• Burden of bacterial bloodstream infection - A brief update on epidemiology and significance of multidrug-resistant pathogens.
  Kern WV, Rieg S. Clin Microbiol Infect 2019. pii: S1198-743X(19)30586-5. doi: 10.1016/j.cmi.2019.10.031.

• Towards an improved diagnosis of bloodstream infection: promises and hurdles.
  Lamy B, Sundqvist M. Clin Microbiol Infect 2018;24:933-934. doi: 10.1016/j.cmi.2018.02.025
• A prospective multicentre study of the epidemiology and outcomes of bloodstream
  infection in cirrhotic patients.
  Bartoletti M, Giannella M, Lewis R, et al. Clin Microbiol Infect 2018;24:546.e1-546.e8. doi: 10.1016/j.cmi.2017.08.001
• Comparison of predictors and mortality between bloodstream infections caused by
  ESBL-producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae.
  Scheuerman O, Schechner V, Carmeli Y, et al. Infect Control Hosp Epidemiol 2018;39:660-667. doi: 10.1017/ice.2018.63
• Predictors of outcome in patients with severe sepsis or septic shock due to
  extended-spectrum β-lactamase-producing Enterobacteriaceae.
  Russo A, Falcone M, Gutiérrez-Gutiérrez B, et al. Int J Antimicrob Agents 2018;52:577-585. doi: 10.1016/j.ijantimicag.2018.06.018

This review gives an update on methods available for determining (i) the susceptibility or resistance of fungal isolates or biofilms to antifungal or antibiofilm compounds and compound combinations; (ii) the in vivo efficacy of antifungal and antibiofilm compounds and compound combinations; and (iii) the in vitro and in vivo performance of anti-infective coatings and materials to prevent fungal biofilm-based infections. Methods for testing antifungal susceptibility and monitoring in vivo performance of antifungal and antimicrobial drugs are extensively described.

• A Prospective Multicentre Study of the Epidemiology and Outcomes of BloodstreamInfection in Cirrhotic Patients. Michele Bartoletti, Maddalena Giannella, Russell Lewis, Paolo Caraceni, Sara Tedeschi, Mical Paul, Christoph Schramm, Tony Bruns, Manuela Merli, Nazaret Cobos-Trigueros, Elena Seminari, Pilar Retamar, Patricia Muñoz, Mario Tumbarello, Patrizia Burra, Maria Torrani Cerenzia, Bruno Barsic, Ester Calbo, Alberto Enrico Maraolo, Nicola Petrosillo, Maria Angeles Galan-Ladero, Giampiero D’Offizi, Noa Bar Sinai, Jesus Rodríguez-Baño, Gabriella Verucchi, Mauro Bernardi, Pierluigi Viale On behalf of ESGBIS/BICHROME study group Clinical Microbiology and Infection. Clinical Microbiology and Infection. 14 August 2017. doi: 10.1016/j.cmi.2017.08.001

• Prediction of unfavorable outcomes in West Nile virus neuroinvasive infection - Result of a multinational ID-IRI study.
  Popescu CP, Florescu SA, Hasbun R, et al. J Clin Virol. 2020 doi: 10.1016/j.jcv.2019.104213.
• A Prospective Cohort Study to Identify Clinical, Biological and Imaging Features That Predict Etiology of Acute Encephalitis
  Le Maréchal  M, Mailles  A, Seigneurin  A et al. Clin Infect Dis 2020 doi: 10.1093/cid/ciaa598.
• Combined therapy with ceftriaxone and doxycycline does not improve the outcome of meningococcal meningitis in mice compared to ceftriaxone monotherapy.
  Ricci S, Grandgirard D, Masouris I et al. BMC Infect Dis2020; 20: 505. doi. 10.1186/s12879-020-05226-w.